- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Risk of progression of Prediabetes to Diabetes minimal in elderly: JAMA
The concept of prediabetes (and similar concepts of impaired fasting glucose and impaired glucose tolerance) formally emerged in the 1990s to better characterize the incremental pathophysiology leading to the eventual development of diabetes. In a recent study, researchers have suggested that the prediabetes may not be a robust diagnostic entity in older age. The study findings were published in the JAMA Internal Medicine on February 08, 2021.
The term prediabetes is used to identify individuals at increased risk for diabetes. It is defined by ranges of disordered glucose values between normal and diabetes (eg. hemoglobin A1c levels, 5.7%-6.4%). In 2017, 352 (7.3%) million adults were living with prediabetes worldwide, and this number is expected to increase to 587 million (8.3%) by 2045. Prediabetes is more common in older than younger people; about 48% of U.S. adults aged ≥65 years had this condition in 2010. However, the natural history of prediabetes in older age is not well characterized. Therefore, researchers of America conducted a study, to compare the different prediabetes definitions and characterize the risks of prediabetes and diabetes among older adults in a community-based setting.
It was a prospective cohort analysis of 3412 older adults without diabetes from the Atherosclerosis Risk in Communities Study (baseline, 2011-2013). Researchers contacted participants semiannually through December 31, 2017, and followed them for 5 visits between January 1, 2016, and December 31, 2017. They defined prediabetes by a glycated hemoglobin (HbA1c) level of 5.7% to 6.4%, impaired fasting glucose (IFG) level (FG level of 100-125 mg/dL), either, or both. The major outcome assessed was incident total diabetes (physician diagnosis, glucose-lowering medication use, HbA1c level ≥6.5%, or FG level ≥126 mg/dL).
Key findings of the study:
♦ During the 6.5-year follow-up period, researchers noted 156 incident total diabetes cases (118 diagnosed) and 434 deaths.
♦ Upon analysis, they noted that
- 44% had HbA1c levels of 5.7% to 6.4%,
- 59% had IFG,
- 73% met the HbA1c or IFG criteria, and
- 29% met both the HbA1c and IFG criteria.
♦ Among participants with HbA1c levels of 5.7% to 6.4% at baseline, they noted 9% progressed to diabetes, 13% regressed to normoglycemia (HbA1c, <5.7%), and 19% died.
♦ Among those with IFG at baseline, they noted that 8% progressed to diabetes, 44% regressed to normoglycemia (FG, <100 mg/dL), and 16% died.
♦ Of those with baseline HbA1c levels less than 5.7%, they found 17% progressed to HbA1c levels of 5.7% to 6.4% and 3% developed diabetes.
♦ Among those with baseline FG levels less than 100 mg/dL, they observed 8% progressed to IFG (FG, 100-125 mg/dL) and 3% developed diabetes.
The authors concluded, "In this community-based cohort study of older adults, the prevalence of prediabetes was high. However, during the study period, regression to normoglycemia or death was more frequent than progression to diabetes. These findings suggest that prediabetes may not be a robust diagnostic entity in older age."
For further information:
https://jamanetwork.com/journals/jamainternalmedicine/article-abstract/2775594
Dr Kartikeya Kohli is an Internal Medicine Consultant at Sitaram Bhartia Hospital in Delhi with super speciality training in Nephrology. He has worked with various eminent hospitals like Indraprastha Apollo Hospital, Sir Gangaram Hospital. He holds an MBBS from Kasturba Medical College Manipal, DNB Internal Medicine, Post Graduate Diploma in Clinical Research and Business Development, Fellow DNB Nephrology, MRCP and ECFMG Certification. He has been closely associated with India Medical Association South Delhi Branch and Delhi Medical Association and has been organising continuing medical education programs on their behalf from time to time. Further he has been contributing medical articles for their newsletters as well. He is also associated with electronic media and TV for conduction and presentation of health programs. He has been associated with Medical Dialogues for last 3 years and contributing articles on regular basis.
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751